DSP Banking & Financial Services Fund - Direct - Growth vs Nippon India Pharma Fund-Growth Plan-Bonus Option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

The DSP Banking & Financial Services Fund - Direct - Growth appears stronger on the star rating with a 4-star rating compared to Nippon India Pharma Fund's 2-star rating, indicating a potentially better quality of management or performance. However, while DSP offers a lower expense ratio of 0.79%, Nippon India Pharma Fund has higher 1-year returns at 11.76% and impressive 3-year and 5-year CAGR figures of 16.54% and 13.76%, respectively, suggesting a tradeoff between higher returns and higher expense ratio. For investors choosing between them, the decision may hinge on whether they prioritize higher recent returns or a more favorable star rating.

DSP Mutual Fund

DSP Banking & Financial Services Fund - Direct - Growth

DSP Mutual Fund

★★★★★

Equity · Sectoral Fund

Nippon India Mutual Fund

Nippon India Pharma Fund-Growth Plan-Bonus Option

Nippon India Mutual Fund

★★★★★

Equity · Sectoral Fund

Metric DSP Banking & Financia... Nippon India Pharma Fu...
NAV ₹15.89 ₹582.42
Star Rating ★★★★ ★★
Expense Ratio 0.79% 0.99%
AUM ₹2,034 Cr ₹9,166 Cr
1M Return +8.06% +8.53%
3M Return +1.24% +2.09%
6M Return +10.45% +6.88%
1Y Return +10.66% +11.76%
3Y CAGR — +16.54%
5Y CAGR — +13.76%
Risk Level — —
Fund Manager Dhaval Gada Sailesh Raj Bhan